| Market Capitalization (Millions $) |
603 |
| Shares
Outstanding (Millions) |
174 |
| Employees |
3,238 |
| Revenues (TTM) (Millions $) |
1,795 |
| Net Income (TTM) (Millions $) |
-3 |
| Cash Flow (TTM) (Millions $) |
0 |
| Capital Exp. (TTM) (Millions $) |
1 |
Business Description
111 Inc, also known as 111, is a leading digital healthcare platform company in China that aims to provide innovative, integrated solutions to customers and partners in the healthcare industry. The company was founded in Shanghai in 2010 and has since expanded to become one of the largest digital healthcare platforms in China.
111 operates several business segments that are designed to cater to the various needs of its customers. The company's main business segments are:
Pharmacy and healthcare services - this segment provides customers with online and offline healthcare services and prescription drug delivery services. The company operates a network of licensed drug stores and medical clinics that offer a range of healthcare services.
B2B pharmaceutical supply chain - this segment connects pharmaceutical manufacturers, distributors, hospitals and other healthcare providers through its digital platform, providing an integrated supply chain solution.
Insurance and healthcare management - a business segment that focuses on providing insurance companies with health management services and insurance products.
111's core services include providing pharmacy and healthcare services, a digital hospital platform and B2B pharmaceutical supply chain services. The company's digital hospital platform operates through its subsidiary DXY, which is a platform that connects patients, doctors and hospitals through its online and offline services. DXY is one of the largest online medical portals in China with over 20 million registered users.
In addition to its core services, 111 has also developed a range of innovative technology products that enhance its service offering. For example, the company's AI technology and big data analytics are used to improve patient experience and improve healthcare outcomes.
111 has a strong presence in China's major cities and has expanded to over 30 provinces and municipalities, covering over 90% of China's population. The company has also established strategic partnerships with leading pharmaceutical companies and healthcare providers in China.
111 Inc is listed on the NASDAQ exchange under the ticker symbol YI. The company has won several awards, including being recognized as an innovative company at the 2019 World Artificial Intelligence Conference.
Company Address: 10th Floor, T1, Yuzhongxin, No.268 Yubei Road, Shanghai 201204
Company Phone Number: 2053-6666 Stock Exchange / Ticker: NASDAQ YI
|
